A novel approach to defining progression in MDS and precursor myeloid conditions in The MDS Natural History Study.
DeZern AE, Gillis N, Otterstatter M, Abel GA, Padron E, Deeg HJ, Al Baghdadi T, Liu JJ, Xie Z, Zhang L, Moscinski LC, Kroft SH, Harrington AM, Foran JM, Komrokji RS, Starczynowski DT, Gore SD, Saber W, Bejar R, Lindsley RC, Sherman S, Lee C, DiFronzo NL, Walter MJ, Sekeres MA.
DeZern AE, et al. Among authors: liu jj.
Blood Adv. 2026 Feb 11:bloodadvances.2025018770. doi: 10.1182/bloodadvances.2025018770. Online ahead of print.
Blood Adv. 2026.
PMID: 41671442